The Key benefits are enhanced learning, elevating focus, decreasing anxiety, and reducing stress and anxiety while improving sleep
Patients with DT2 without obesity or excess weight with comorbidities can use liraglutide 1.8mg (daily, subcutaneous) and semaglutide 1mg (weekly, subcutaneous), or 14mg (daily, oral) for glycemic control
This broader structure is useful when side effects begin to interfere with nutrition or adherence
Wear loose clothing that allows easy access to the injection site (typically the upper arm)
You might feel it in your throat or neck
Promotes Satiety: It acts on the brain to help you feel satisfied and less hungry, which can lead to weight loss